R&D The future of drug development: Integrating open source and ... Clinical trials for drug development are becoming increasingly complex, with numerous variables that must be identified and defined from the start.
Partner Content Partner Content Is there a faster way to build clinical trials? Easier and faster Clinical Trials with Clinical MDR.
Partner Content Partner Content Why switch to automated CRF annotations? Why it's best to automate CRF annotations
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.